Crossmark

Experiences of using a digital tool, the D‐foot, in the screening of risk factors for diabetic foot ulcers

Crossref DOI link: https://doi.org/10.1186/s13047-022-00594-9

Published Online: 2022-12-13

Published Print: 2022-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zügner, Roland http://orcid.org/0000-0001-8263-2017
Jarl, Gustav

Sundberg, Leif

Tang, Ulla Hellstrand
Funding

Funding for this research was provided by:

Göteborgs Universitet

Doktor Felix Neuberghs Stiftelse

Familjen Knut &Ragnvi Jacobssons Stiftelse

Stiftelsen Promobilia

Stiftelsen Skobranchenens Utvecklingsfond

Stiftelsen Gunnar Holmgrens minne

IngaBritt och Arne Lundbergs Forskningsstiftelse

Adlerbertska Stiftelserna

Greta och Einar Askers Stiftelse

Hans Dahlbergs Stiftelse för Miljö och Hälsa

Svergies Ortopedingengörers förening

Diabetesfonden

The Gothenburg Diabetic Assosiation

Västra Götalandsregionen

University of Gothenburg
License Information

Version of Record valid from 2022-12-13

Text and Data Mining valid from 2022-01-01

Version of Record valid from 2022-12-13
More Information

Article History

Received: 19 August 2022

Accepted: 25 November 2022

First Online: 13 December 2022

Declarations

:

: The study was approved by the ethical review board in Gothenburg, reference number: 2019–01039. All the patients and the CPOs received oral and written information about the study and their right to withdraw from the study at any time without explanation. The patients and CPOs signed a written consent after they had received verbal and written information. The study was carried out in accordance with the Code of Ethics of the World Medical Association, the Declaration of Helsinki, for experiments involving humans [CitationRef removed].

: Not applicable.

: GJ is a consultant for Novo Nordisk. The other authors declare no competing interests.

Document is current

Any future updates will be listed below